- Home
- /
- Treatment
- /
- Page 13
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Fast skeletal muscle troponin activator | Spinal muscular atrophy | Cytokinetics, Inc.;280 East Grand Avenue;South San Francisco, California, 94080 | May 11, 2017 | |
2-amino-1-[2-(4-fluoro-phenyl)-3-(4-fluoro-phenyl)amino)-8,8-dimethyl-5,6-dihydro-imidazo[1,2-a]pyrazin-7(8H)-yl)-ethanone diphosphate | Malaria | Novartis Pharmaceuticals Corporation;1 Health Plaza;East Hanover, New Jersey, 07936 | May 11, 2017 | |
Povidone-iodine 0.5% (w/w) in dimethylsulfoxide 44% (w/w) | Microbial keratitis (which includes Acanthamoeba keratitis) | Veloce BioPharma LLC;7008 Lafayette Avenue;Fort Washington, Pennsylvania, 19034 | May 11, 2017 | |
Ritanserin | Glioblastoma | The University of Virginia/Benjamin Purow;1215 Lee Street;Charlottesville, Virginia, 22908 | May 11, 2017 | |
Rilonacept | Deficiency of interleukin-1 receptor antagonist (DIRA) | Regeneron Pharmaceuticals, Inc.;777 Old Saw Mill River Road;Tarrytown, New York, 10591 | May 9, 2017 | |
Humanized anti-CD19, Fc engineered, monoclonal antibody with enhanced binding to FcyRIIb | Immunoglobulin G4-related disease | Xencor, Inc.;111 West Lemon Avenue;Monrovia, California, 91016 | May 9, 2017 | |
Larotrectinib | Solid tumors with NTRK-fusion proteins | Loxo Oncology, Inc.;281 Tresser Boulevard, 9th Floor;Stamford, Connecticut, 06901 | May 9, 2017 | |
Autologous CD34+ hematopoietic stem cells transduced with an hCD11b lentiviral vector encoding for the human N-sulfoglucosamine sulfohydrolase (SGSH) gene | Mucopolysaccharidosis IIIA | Orchard Therapeutics North America;1118 Chess Drive, Suite A;Foster City, California, 94404 | May 3, 2017 | |
Recombinant adeno-associated viral vector, AAV2 serotype 6 (rAAv2/6), expressing human factor 8 (hf8) cDNA | Hemophilia A | Sangamo Therapeutics, Inc.;Point Richmond Tech Center, 501 Canal Boulevard;Richmond, California, 94804 | May 3, 2017 | |
Cisplatin loaded hyaluronate film for implant | Malignant pleural mesothelioma | PlumeStars s.r.l.;Via Lago Scuro11, 43124 Parma; | May 2, 2017 | |
Macromolecular conjugate of heparin sodium on a polymer backbone | Prevention of ischemia-reperfusion injury associated with solid organ tranplantation | Corline Biomedical AB;5 Lefflersgatan;Uppsala | May 2, 2017 | |
Estetrol | Neonatal encephalopathy | Mithra Pharmaceuticals S.A. | April 28, 2017 | |
Mutated isocitrate dehydrogenase 1 (IDH1) inhibitor | Acute myeloid leukemia | FORMA Therapeutics, Inc.;500 Arsenal Street, Suite 100;Watertown, Massachusetts, 02472 | April 27, 2017 | |
Ivosidenib | Bile duct cancer | Agios Pharmaceuticals, Inc.;88 Sidney Street;Cambridge, Massachusetts, 02139 | April 26, 2017 | |
Ivosidenib | Bile duct cancer | Agios Pharmaceuticals, Inc.;88 Sidney Street;Cambridge, Massachusetts, 02139 | April 26, 2017 | |
Small molecule Mas receptor agonist | Duchenne muscular dystrophy | RASRx, LLC;231 Bonetti Drive, Suite 240;San Luis Obispo, California, 93401 | April 25, 2017 | |
(S)-8-{2-amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester | Pulmonary Arterial Hypertension | Biological Consulting Europe Ltd | April 20, 2017 | |
Autologous adult bone marrow-derived non-expanded CD133+ haematopoietic stem cells | Asherman's syndrome | Igenomix, S.L. | April 20, 2017 | |
Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human B cell maturation antigen with 4-1BB and CD3-zeta intracellular signalling domains | Multiple myeloma | Celgene Europe Limited | April 20, 2017 | |
Emeramide | Prevention of mercury toxicity | NBMI Science Limited | April 20, 2017 | |
Human normal immunoglobulin | Treatment in solid organ transplantation | Hôpital Foch | April 20, 2017 | |
Modified messenger ribonucleic acid encoding human ornithine transcarbamylase enzyme encapsulated into lipid nanoparticles | Ornithine Transcarbamylase Deficiency | PhaseRx Ireland, Ltd | April 20, 2017 | |
N-[(1R)-1-phenylethyl]-6-{1H-pyrazolo[3,4-d]pyrimidin-4-yl}quinazolin-2-amine | Fragile X syndrome | Sentinel Oncology Limited | April 20, 2017 | |
Rituximab | Treatment in solid organ transplantation | Hôpital Foch | April 20, 2017 | |
Thymidine and deoxycytidine | Mitochondrial DNA depletion syndrome, myopathic form | Vall d'Hebron Institute of Research | April 20, 2017 |